334
Views
25
CrossRef citations to date
0
Altmetric
Articles

Identifying miRNA regulatory mechanisms in preeclampsia by systems biology approaches

, &
Pages 90-99 | Received 30 May 2016, Accepted 16 Sep 2016, Published online: 11 Nov 2016

References

  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33(3):130–7.
  • Uzan J, Carbonnel M, Piconne O, et al. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manage 2011;7:467.
  • Enquobahrie DA, Meller M, Rice K, et al. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 2008;199(5):566.e1–11.
  • Meng T, Chen H, Sun M, et al. Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. OMICS 2012;16(6):301–11.
  • Baek D, Villén J, Shin C, et al. The impact of microRNAs on protein output. Nature 2008;455(7209):64–71.
  • Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011;91(3):827–87.
  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6(11):857–66.
  • O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010;10(2):111–22.
  • Fu G, Brkić J, Hayder H, Peng C. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci 2013;14(3):5519–44.
  • Mouillet J-F, Ouyang Y, Coyne CB, Sadovsky Y. MicroRNAs in placental health and disease. Am J Obstet Gynecol 2015;213(4):S163–72.
  • Jairajpuri DS, Almawi WY. MicroRNA expression pattern in pre-eclampsia (Review). Mol Med Rep 2016;13(3):2351–8.
  • Stubert J, Koczan D, Richter D-U, et al. miRNA expression profiles determined in maternal sera of patients with HELLP syndrome. Hypertens Pregnancy 2014;33(2):215–235
  • Guo L, Tsai SQ, Hardison NE, et al. Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas. Placenta 2013;34(7):599–605.
  • Ohlsson Teague EMC, Van der Hoek KH, Van der Hoek MB, et al. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009;23(2):265–75.
  • Dong F, Zhang Y, Xia F, et al. Genome-wide miRNA profiling of villus and decidua of recurrent spontaneous abortion patients. Reproduction 2014;148(1):33–41.
  • The Gene Expression Omnibus Database. http://www.ncbi.nlm.nih.gov/geo. Accessed 2 Nov 2015.
  • Nishizawa H, Pryor-Koishi K, Kato T, et al. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007; 28 (5–6): 487–97.
  • Martin E, Ray PD, Smeester L, et al. Epigenetics and preeclampsia: Defining functional epimutations in the preeclamptic placenta related to the TGF-β Pathway. PLoS One 2015;10(10):e0141294.
  • Sitras V, Paulssen RH, Grønaas H, et al. Differential placental gene expression in severe preeclampsia. Placenta 2009;30(5):424–33.
  • Nishizawa H, Ota S, Suzuki M, et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 2011;9:107.
  • Tsai S, Hardison NE, James AH, et al. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta 2011;32(2):175–82.
  • The R Project for Statistical Computing. https://www.r-project.org. Accessed 5 November 2015.
  • Bioconductor Open Source Software for Bioinformatics. https://www.bioconductor.org. Accessed 5 November 2015.
  • Sales G, Coppe A, Bisognin A, et al. Magia, a web-based tool for miRNA and genes integrated analysis. Nucleic Acids Res 2010;38(SUPPL. 2):352–9.
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13(11):2498–504.
  • The Human Protein Reference Database. http://www.hprd.org. Accessed 4 Dec 2015.
  • The Human Protein Atlas. http://www.proteinatlas.org. Accessed 4 Dec 2015.
  • DAVID Bioinformatics Database. http://david.ncifcrf.gov. Accessed 11 Dec 2015.
  • GeneCards Suite Integrated Knowledgebase. http://geneanalytics.genecards.org. Accessed 15 Dec 2015.
  • VarElect: The Next Generation Sequencing Phenotyper. http://ve.genecards.org. Accessed 15 Dec 2015.
  • MalaCards: The Human Disease Database. http://www.malaards.org. Accessed 15 Dec 2015.
  • Kojima T, Yamada T, Akaishi R, et al. Role of the Atg9a gene in intrauterine growth and survival of fetal mice. Reprod Biol 2015;15(3):131–8.
  • Nagashima T, Li Q, Clementi C, et al. BMPR2 is required for postimplantation uterine function and pregnancy maintenance. J Clin Invest 2013;123(6):2539–50.
  • Saben J, Zhong Y, McKelvey S, et al. A comprehensive analysis of the human placenta transcriptome. Placenta 2014;35(2):125–31.
  • Popovici RM, Betzler NK, Krause MS, et al. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology 2006;147(12):5662–75.
  • Guo J, Tian T, Lu D, et al. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia. J Obstet Gynaecol Res 2012;38(7):988–96.
  • Mistry HD, McCallum LA, Kurlak LO, et al. Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia. Hypertension 2011;58(3):497–504.
  • Racca AC, Ridano ME, Camolotto S, et al. A novel regulator of human villous trophoblast fusion: The Krüppel-like factor 6. Mol Hum Reprod 2015;21(4):347–58.
  • Lian IA, Langaas M, Moses E, Johansson Å. Differential gene expression at the maternal-fetal interface in preeclampsia is influenced by gestational age. PLoS One 2013;8(7):e69848.
  • Xiang Y, Zhang X, Li Q, et al. Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population. Mol Hum Reprod 2013;19(3):153–9.
  • Guo C, Cao X, Wang Q, et al. Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women. J Assist Reprod Genet 2015;32(10):1525–30.
  • Tejera E, Bernardes J, Rebelo I. Co-expression network analysis and genetic algorithms for gene prioritization in preeclampsia. BMC Med Genomics 2013;6:51.
  • Many A, Hubel CA, Fisher SJ, et al. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000;156(1):321–31.
  • Wang W, Feng L, Zhang H, et al. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 2012;97(6):E1051–9.
  • Harapan H, Andalas M. The role of microRNAs in the proliferation, differentiation, invasion, and apoptosis of trophoblasts during the occurrence of preeclampsia—A systematic review. Tzu Chi Med J. 2015;27(2):54–64.
  • Chan YC, Khanna S, Roy S, Sen CK. MiR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem 2011;286(3):2047–56.
  • Chen D, Wang W. Human placental microRNAs and preeclampsia. Biol Reprod 2013;88(5):130.
  • Song J, Li Y, An RF. Identification of early-onset preeclampsia-related genes and microRNAs by bioinformatics approaches. Reprod Sci 2015;22(8):954–63.
  • Ishibashi O, Ohkuchi A, Ali MM, et al. Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: A novel marker for predicting preeclampsia. Hypertension 2012;59(2):265–73.
  • Cross CE, Tolba MF, Rondelli CM, et al. Oxidative stress alters miRNA and gene expression profiles in villous first trimester trophoblasts. Biomed Res Int 2015;2015:257090.
  • Delfino KR, Rodriguez-Zas SL. Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence. PLoS One 2013;8(3):e58608.
  • Quitadamo A, Tian L, Hall B, Shi X. An integrated network of microRNA and gene expression in ovarian cancer. BMC Bioinf 2015;16(Suppl 5):S5.
  • Schmeier S, Schaefer U, Essack M, Bajic VB. Network analysis of microRNAs and their regulation in human ovarian cancer. BMC Syst Biol 2011;5(1):183.
  • Aure MR, Jernström S, Krohn M, et al. Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer. Genome Med 2015;7(1):21.
  • Bhajun R, Guyon L, Pitaval A, et al. A statistically inferred microRNA network identifies breast cancer target miR-940 as an actin cytoskeleton regulator. Sci Rep 2015;5:8336.
  • Lee C-H, Kuo W-H, Lin C-C, et al. MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer. Int J Mol Sci 2013;14(6):11560–606.
  • Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: A master regulator of microRNA biogenesis and activity. Free Radic Biol Med 2013;64:20–30.
  • Anton L, Olarerin-George AO, Schwartz N, et al. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol 2013;183(5):1437–45.
  • Wareing M, Greenwood SL. Review: Potassium channels in the human fetoplacental vasculature. Placenta 2011;32(Suppl 2):S203–6.
  • Wadehra M, Dayal M, Mainigi M, et al. Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev Biol 2006;292(2):430–41.
  • Buckberry S, Bianco-Miotto T, Roberts CT. Imprinted and X-linked non-coding RNAs as potential regulators of human placental function. Epigenetics 2014;9(1):81–9.
  • Hausser J, Zavolan M. Identification and consequences of miRNA–target interactions — beyond repression of gene expression. Nat Rev Genet 2014;15(9):599–612.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.